[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

B Killingley, AJ Mann, M Kalinova, A Boyers… - Nature Medicine, 2022 - nature.com
safety analysis of this first SARS-CoV-2 human challenge study in young adults, viral kinetics
over the course of primary infection with SARS-CoV-2 … and strategies to affect SARS-CoV-2 …

[HTML][HTML] SARS-CoV-2 and risk to food safety

LECM Anelich, R Lues, JM Farber, VR Parreira - Frontiers in Nutrition, 2020 - frontiersin.org
… of the causal agent, SARS-CoV-2 to humans and its potential effect on food safety and food
… whether the virus poses a risk to food safety. The current contribution provides an exposé of …

Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety

MT Mascellino, F Di Timoteo… - Infection and drug …, 2021 - Taylor & Francis
SARS-CoV-2 affects mainly the respiratory system with most … The anti-CoV-2 vaccines
were developed in a much shorter … before being used in humans, whereas the anti-SARS-CoV-2 …

[HTML][HTML] From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

C Ma, S Su, J Wang, L Wei, L Du, S Jiang - Microbes and Infection, 2020 - Elsevier
… of S protein between SARS-CoV-2 and SARS CoV, it was found that the similarities of primary
sequence between SARS-CoV-2-S and SARS-CoV-S (isolated from human, civet or bat) …

Human safety, tolerability, and pharmacokinetics of molnupiravir, a novel broad-spectrum oral antiviral agent with activity against SARS-CoV-2

WP Painter, W Holman, JA Bush… - Antimicrobial agents …, 2021 - Am Soc Microbiol
… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human airway epithelial cell …
coronavirus (SARS-CoV) or Middle East respiratory syndrome coronavirus (MERS-CoV) …

Safety and effectiveness of SARSCoV‐2 vaccines: a systematic review and meta‐analysis

Y Ling, J Zhong, J Luo - Journal of medical virology, 2021 - Wiley Online Library
… Objective: To systematically evaluate the effectiveness and safety of the SARS-CoV-2
vaccines currently undergoing clinical trials. Methods: PubMed, EMBASE, and Cochrane Library …

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

LR Baden, HM El Sahly, B Essink… - New England journal …, 2021 - Mass Medical Soc
… -based vaccine that encodes the prefusion stabilized full-length spike protein of the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. …

An overview of SARS-CoV-2 and technologies for detection and ongoing treatments: a human safety initiative

R Kurrey, A Saha - Covid, 2022 - mdpi.com
… On the basis of social and human safety, we suggest that fundamental research focus … to
humans and have biological characteristics. This review also illustrates the spread of SARS-CoV

Camostat mesylate against SARSCoV‐2 and COVID‐19—Rationale, dosing and safety

P Breining, AL Frølund, JF Højen… - Basic & clinical …, 2021 - Wiley Online Library
… studies of SARS-CoV-2 in a human lung cell line and primary human lung … SARS-CoV-2
spike protein driven cellular entry. Cell entry in a human colon epithelium cell line by SARS-CoV

Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults

EJ Anderson, NG Rouphael, AT Widge… - … England Journal of …, 2020 - Mass Medical Soc
… with high-dose intranasal SARS-CoV-2 rapidly cleared the … Thus, the testing of SARS-CoV-2
vaccine candidates in older … Here, we report preliminary safety and immunogenicity data …